Clinical Trial on Treatment of Intraventricular Hemorrhage

NCT00650858 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Intraventricular Hemorrhage

Interventions

DRUG: tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo)

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]